Cadmium is a ubiquitous environmental contaminant, and it is known to be a highly toxic metal. The level of cadmium in the environment has risen with advances in industrialization, and the role of cadmium in human diseases is of increasing concern. The mechanisms of cadmium toxicity are poorly understood. However, cadmium is thought to cause harmful effects in multiple ways, including production of reactive oxygen species (ROS).
The thioredoxin (Trx) system, which consists of Trx and Trx reductase (TrxR), is one of the major enzymatic systems modulating intracellular ROS levels. Trx is a small redox-active protein that reduces a wide range of substrates by reversible oxidation of its active center dithiol to a disulfide.
3)
The Trx system is involved in many cellular functions. 4) Oxidized Trx, which does not exert its biological effects, can be reduced by receiving electrons from NADPH via TrxR. Since TrxR is the only class of enzymes known to reduce oxidized Trx, activity of this enzyme is thought to be an important factor in regulating the activity of the Trx system. 5) Mammalian TrxR is a selenoprotein containing a penultimate Cterminal selenocysteine residue essential for its catalytic activity. To date, three mammalian TrxR isozymes have been identified: cytosolic form (TrxR1), mitochondrial form (TrxR2), and testis-specific form (TrxR3). 6, 7) Among these three isozymes, TrxR1 is the most well characterized and is known to be inducible in response to various stimuli, including peroxynitrite, 8) phorbol ester, interleukin 1b, 9) and tumor necrosis factor a. 10) We have recently reported that cadmium also up-regulates the TrxR1 mRNA level in bovine arterial endothelial cells by activating NF-E2-related factor 2 (Nrf2), a stress-responsive transcriptional factor. 11) Nrf2 is activated by cadmium 12) and is shown to be involved in hemin-induced Trx gene expression 13) as well as TrxR1 gene expression. However, physiological or pathological roles of the induction of TrxR1 gene expression have not been fully elucidated. In the present study, we attempted to clarify the biological meaning of this induction, that is, to determine whether cadmium-induced TrxR1 plays an important role in cellular defense against cadmium toxicity. It is known to be difficult to overexpress enzymatically active selenoproteins such as TrxR in mammalian cells. 14) Therefore, knockdown of TrxR1 by antisense 15) or small interfering RNA (siRNA) 16) seems to be more sound way to examine its intracellular function. Very recently, Seemann and Hainaut reported that transfection of TrxR1 siRNA led to a downregulation of TrxR1 protein with a decrease of over 90% at 48 h after transfection. 16) We here silenced the expression of TrxR1 in HeLa cells by using siRNA and examined the effect of gene silencing of TrxR1 on the sensitivity of the cells toward cadmium-induced cell death.
MATERIALS AND METHODS
Cell Culture HeLa (human cervix carcinoma) cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS), penicillin and streptomycin, in an atmosphere of 5% CO 2 at 37°C.
siRNA Transfection Twenty-one-bp double-stranded RNAs were designed as follows, and obtained from QIAGEN (Hilden, Germany): hTrxR1 target sequence, sense 5Ј-UGAUAGAAGCUGUACAGAAdTdT-3Ј and antisense 5Ј-UUCUGUACAFCUUCUAUCAdTdT-3Ј, and control sequence with no homology to the human genome, sense 5Ј-AGUUCAACGACCAGUAGUCdTdT-3Ј and antisense 5Ј-GACUACUGGUCGUUGAACUdTdT-3Ј. Cells were seeded in 10-cm dishes (1ϫ10 6 cells/dish) and precultured for 24 h before transfection, and then cells were rinsed with Opti-MEM I (Invitrogen, Carlsbad, CA, U.S.A.) and transfection of siRNAs was carried out at a final concentration of 64 nM using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instruction. After 5 h of incubation, medium was replaced with DMEM containing 10% FBS. Cells were cul-tured for an additional 40 h before experiments were begun.
Northern Blot Analysis TrxR1 mRNA expression was analyzed as previously described. 11) Briefly, HeLa cells were treated with 10 mM of cadmium chloride or sodium arsenite for 6 h, and then harvested. Twenty micrograms of total RNA isolated from the harvested cells was denatured with formamide, electrophoresed on a 1% agarose gel, and transferred to a PhotoGene nylon membrane (Life Technologies, Inc., Rockville, MD, U.S.A.). The blots were hybridized with [ 32 P]-labelled cDNAs for TrxR1. The mRNA levels were calculated on the basis of hybridization signals measured by a Fujix Bio-imaging analyzer BAS2000 (Fuji Photo Film Co., Tokyo, Japan).
MTT Assay
We seeded siRNA-transfected cells in 96 well-plates (3ϫ10 3 cells/well) and then cultured them for 24 h. The medium was changed to DMEM supplemented with 0.5% FBS before the addition of CdCl 2 , NaAsO 2 , HgCl 2 or H 2 O 2 . After 24 or 48 h of incubation, 50 mg/well of MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) was added, and then cells were further cultured for 2 h to produce MTT formazan. Cells were lysed by the addition of 100 ml of cell lysis solution (50% N,N-dimethylformamide, 20% SDS, 2% acetic acid, 0.04% HCl). Cell viability was determined by measuring the absorbance (570 nm) and calculating a percentage compared to the non-treated group.
Statistics The data were analyzed by ANOVA followed by the post hoc Tukey test. Differences were considered significant at values of pϽ0.05.
RESULTS

Gene Silencing of TrxR1 in HeLa Cells
We first examined the effects of control and TrxR1 siRNA on TrxR1 mRNA expression in HeLa cells (Fig. 1) . HeLa cells were transiently transfected with each siRNA, and TrxR1 mRNA levels were assayed by Northern blot analysis. In cells transfected with control siRNA (control cells), TrxR1 mRNA was constitutively expressed and was elevated in response to both cadmium and arsenite for 6 h. In contrast, cells transfected with TrxR1 siRNA (iTrxR1 cells) expressed a much lower level of TrxR1 mRNA under unstimulated conditions, and they showed only a weak induction in the presence of either cadmium or arsenite. On the other hand, mRNA levels of metallothionein, which is also induced by cadmium, were not affected by TrxR1 siRNA (data not shown). These results indicate that TrxR1 siRNA is sufficiently effective to suppress TrxR1 expression.
Effects of TrxR1 Gene Silencing on the Cell Sensitivity toward Cadmium We first determined the cell viability after 48 h of cadmium treatment by MTT assay (Fig. 2A) . In the presence of a low concentration of cadmium, less than 10 mM, control cells survived at a higher rate than did iTrxR1 cells, suggesting that TrxR1 might contribute to cell protection against cadmium. In contrast, in the presence of a higher dose of cadmium, the TrxR1 gene silencing had the opposite effect, resulting in iTrxR1 cells being more viable than control cells. We further examined the effect of TrxR1 gene silencing on the cell viability after 24 h of cadmium treatment (Fig. 2B) . In this case, the cell protective effect of TrxR1 against a lower dose of cadmium was not observed, and iTrxR1 cells were more viable than control cells throughout the toxic range of concentration of cadmium (more than 5 mM).
Effects of TrxR1 Gene Silencing on the Cell Sensitivity toward Arsenite, Mercury and Hydrogen Peroxide To reveal the mechanism of how TrxR1 gene silencing affects the cell sensitivity toward cadmium, we then examined the effect of TrxR1 silencing on the sensitivity toward other cytotoxic compounds such as arsenite, inorganic mercury and hydrogen peroxide. There was only a little but significant difference in cell viability between control and iTrxR1 cells after treatment with arsenite (Fig. 2C) . The effect of TrxR1 silencing on the sensitivity toward arsenite was almost similar to that toward cadmium. On the other hand, when cells were treated with inorganic mercury or hydrogen peroxide, iTrxR1 cells survived at a higher rate than control cells throughout the toxic range of concentration (Figs. 2D, E) . The hypersensitivity which was observed in lower levels of cadmium-treated iTrxR1 cells was not observed in these two compounds-treated cells.
DISCUSSION
In the present study, we found that the gene silencing of TrxR1 had a dual effect on cadmium-induced cell death, depending on the concentration of cadmium. Since TrxR1 has an antioxidative activity 5) and antioxidant enzymes such as glutathione peroxidase and glutaredoxin function as cytoprotective molecules, [17] [18] [19] we had expected that when its expression is impaired by siRNA, the cytotoxic effect of cadmium would be intensified and cell viability would be decreased. As we had presumed, iTrxR1 cells were more sensitive toward a low dose (less than 10 mM) of cadmium ( Fig.  2A) . Although, in the presence of a high dose of cadmium, iTrxR1 cells were more viable than control cells, the concentration of cadmium could rarely be higher than 10 mM in biological conditions. Therefore, it seemed that TrxR1 might contribute to rescuing cells from cadmium toxicity in a practical environment.
How does TrxR1 protect cells from death promoted by cadmium? One possible answer is that TrxR1 may chelate cadmium ions directly and detoxify their harmfulness. TrxR1 contains a dithiol and a selenol redox-active motif in the catalytic site, which is likely to bind to heavy metals in high affinity. 5) However, there were only a little or no cell protective effects against arsenite and inorganic mercury, although both of them are also known to bind to dithiol construction in high affinity (Figs. 2C, D) . The chelating potency of TrxR1 544
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Fig. 1. Gene Silencing of TrxR1 in HeLa Cells
HeLa cells were transiently transfected with control or TrxR1 siRNA and cultured with or without 10 mM of cadmium chloride or sodium arsenite for 6 h. mRNA expression levels were examined by Northern blot analysis. A b-actin probe was used as a loading control.
might not contribute to the detoxication of cadmium. Another possibility is that TrxR1 may scavenge intracellular ROS produced by cadmium. Cadmium is thought to cause harmful effects in multiple ways, including the production of ROS. 1, 2) However, as the knockdown of TrxR1 did not elevate hydrogen peroxide-induced cell death (Fig. 2E) , this possibility may also be excluded.
We speculate that the gene silencing of TrxR1 might protect the cells from cadmium by altering the activity of stressresponsive transcription factors whose activities are regulated by the Trx system. DNA binding of several kinds of transcription factors, such as AP-1 and NF-kB, is promoted by Trx in the nucleus. 20, 21) TrxR1 is also reported to regulate activities of AP-1 and p53, 16, 22) in addition to DNA binding of NF-kB as we indicated previously. 10) As the target genes of these transcription factors produce various cell-protective components and anti-apoptotic products, 3) the TrxR1 silencing might suppress the induction of these gene products and then increase sensitivity toward cadmium. It was reported that in rat proximal tubule cells, cadmium-induced NF-kB activation could contribute to detoxification by increasing the expression of multidrug-resitance P-glycoprotein and extruding cadmium from cells. 23) Furthermore, Seemann and Hainaut recently showed that silencing of TrxR1 activated some p53-responsive genes. 16) TrxR1 might regulate the expression of cytoprotective genes and then detoxify intracellular cadmium. This speculation is consistent with our present observation that TrxR1 gene silencing did not decrease the cell viability after 24 h of cadmium treatment (Fig. 2B) . TrxR1-mediated cell protection against cadmium might be caused by an indirect pathway that involves a variety of gene expressions. However, further studies are needed to clarify the mechanism how TrxR1 protects cells from a low dose of cadmium.
Although we had expected that TrxR1 siRNA would decrease the cadmium-treated cell viability throughout the toxic range of cadmium concentration, iTrxR1 cells were more viable than control cells under exposure to a higher dose of cadmium (Figs. 2A, B) . High doses of arsenite-, inorganic mercury-or hydrogen peroxide-treated iTrxR1 cells also survived at a higher rate than control cells (Figs. 2C, D,  E) . These results suggested that TrxR1 might promote cell death under these conditions. Anestål et al. recently reported that selenium-compromised TrxR1 induced apoptosis in human A549 cells. 24) They showed that truncated seleniumdeficient TrxR1, or forms of the enzyme compromised at the selenocysteine residue with either cisplatin or dinitrophenyl moieties, rapidly induced cell death, but the enzymatically active full-length enzyme did not have this property. Although the mechanism of how such forms of TrxR1 promoted apoptosis within a short time are still unknown, the cell death might be provoked in a direct and dominant manner. Selenium is known to interact with several kinds of metal, including cadmium and mercury, and yield metal selenides or protein complexes thereof spontaneously in vivo. 25) It was therefore suggested that the selenocysteine residue of TrxR1 might interact with cadmium or mercury to form selenium-compromised TrxR1, which is enzymatically inactive and may not have a cytoprotective activity, and then the selenium-compromised TrxR1 might consequently induce cell death. Since the formation of selenium-compromised TrxR1 might be decreased in iTrxR1 cells, iTrxR1 cells might be more viable than control cells.
In summary, we here found that the gene silencing of TrxR1 had a dual, that is, cytoprotective and cytotoxic, effect on cadmium-induced cell death that was dependent on the concentration of cadmium and the exposure time. TrxR1 could determine whether cells should be defended against moderate toxicity or be put out of the way when severely injured, and choose the better way to maintain the whole body according to circumstances. Although we do not know what the sensor might be that would switch the function of TrxR1, the fate of cells might be determined by the intracellular amount of cadmium.
